olivLaw · European equity research
Fast Ejendom Danmark A FED.CO
Denmark · Nasdaq Copenhagen · ISIN DK0060522746 · Vertical: Listed companies from Denmark
At the close of 05 Nov 2026, Fast Ejendom Danmark A (FED.CO) stock was 232.00 DKK (+0.00% on the day), with market capitalisation 604.0 m DKK, P/E 6.4 on diluted EPS of 36.02 DKK over the last 12 months, beta 0.20, 52-week range 192.00–236.00 DKK.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 58.0
- strong (55–70)
- Bollinger (20, 2)
- 223.73 – 235.67
- in the upper half of the band · %B 0.69 · band width 5.2%
- SMA 50 / 200
- 226.88 / 220.82
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 1.85 / 1.76
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +2.7% | +0.4% | +2.3 pp | — |
| 3 months | +5.5% | −3.3% | +8.7 pp | — |
| 6 months | +2.7% | +4.0% | −1.3 pp | — |
| Year to date | +6.4% | +8.1% | −1.7 pp | — |
| 1 year | +16.6% | +10.7% | +5.9 pp | −6.5% |
| 3 years | +96.6% | +50.1% | +46.5 pp | +1.4% |
| 5 years | +71.9% | +43.6% | +28.2 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 100 percentile of its own 1-quarter history (min 6.1, median 6.1, max 6.1; quarters with earnings only).
Fiscal years
| Fiscal year | 2025 |
|---|---|
| Revenue | unavailable |
| Revenue YoY | unavailable |
| Net income | 94.1 m |
| Net income YoY | unavailable |
| Diluted EPS | 36.02 |
| Diluted EPS YoY | unavailable |
| net % | unavailable |
| Free cash flow | 44.1 m |
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 34.8 m DKK
- Financial debt
- unavailable DKK
- Net debt
- unavailable DKK
- Equity
- 791.4 m DKK
- Total assets
- 1.7 bn DKK
- Debt / equity
- unavailable
- Current ratio
- 1.43x
- ROE
- unavailable
- ROA
- 5.5%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (DKK)
Income statement · DKK
| Line | 2025 | Source (latest year) |
|---|---|---|
| Gross profit | 144.4 m | esef· 02 Sept 2026verified |
| Operating income | 131.4 m | esef· 02 Sept 2026verified |
| Interest expense | 30.7 m | esef· 02 Sept 2026verified |
| Pre-tax income | 100.6 m | esef· 02 Sept 2026verified |
| Income tax | 11.6 m | esef· 02 Sept 2026verified |
| Net income | 94.1 m | esef· 29 Apr 2026verified |
| Diluted EPS | 36.02 | esef· 29 Apr 2026verified |
Balance sheet · DKK
| Line | 2025 | Source (latest year) |
|---|---|---|
| Cash | 34.8 m | esef· 29 Apr 2026verified |
| Receivables | 5.7 m | esef· 29 Apr 2026verified |
| Current assets | 83.8 m | esef· 29 Apr 2026verified |
| Total assets | 1.7 bn | esef· 29 Apr 2026verified |
| Current liabilities | 58.6 m | esef· 29 Apr 2026verified |
| Equity | 791.4 m | esef· 29 Apr 2026verified |
| Shares outstanding at year end | 2.6 m | esef· 02 Sept 2026derived |
Cash flow · DKK
| Line | 2025 | Source (latest year) |
|---|---|---|
| Operating cash flow | 44.4 m | esef· 29 Apr 2026verified |
| Capex | 374.0 k | esef· 29 Apr 2026verified |
| Free cash flow | 44.1 m ≈ | esef· 29 Apr 2026derived |
| Investing cash flow | -10.9 m | esef· 29 Apr 2026verified |
| Financing cash flow | -15.7 m | esef· 29 Apr 2026verified |
| Share repurchases | 5.2 m | esef· 29 Apr 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- score weight coverage: 41.7% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: 604.0 m DKK
Key indicators
Coverage and freshness
Score by group
42% · Insufficient data
Estimated value range
unavailable — no valuation assumptions for the reporting currency
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
Assumptions (illustrative, editorial)
- Risk-free rate
- 6.5%
- Equity risk premium
- 6.0%
- Beta (default)
- 1.00
- Cost of equity
- 12.5%
- Terminal growth
- 3.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 41.7% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | unavailable | unavailable | — |
| FCF conversion · Quality | 46.8% | 24 (on a fixed band) | 15% |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 4.3x | 43 (on a fixed band) | 15% |
| Current ratio · Balance sheet | 0.9x | 8 (on a fixed band) | 10% |
| P/E (TTM) · Valuation | 6.4x | 83 (vs peers) | 25% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 7.3% | 91 (on a fixed band) | 20% |
| Shareholder yield (distributions) · Returns | 0.9% | 12 (on a fixed band) | 15% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet29/100 · 2/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality· partial24/100 · 1/3 factors with a value
- Returns· partial12/100 · 1/2 factors with a value
- Valuation86/100 · 2/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
FAST EJENDOM DANMARK A/S (FED.CO). Latest full fiscal year: 2025; data up to 2026-09-30.
Figures computed from the financial statements: ROE 12.2%.
The estimated value range is 400.89–610.42 DKK per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 474.36 DKK, the price of 232.00 DKK leaves a potential of 104.5% (value / price − 1) and a margin of safety of 51.1% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 41.7% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- P/E (TTM): 6.4x
- FCF yield: 7.3%
- The price is below the estimated value range
What contradicts it
- FCF conversion: 46.8%
- Current ratio: 0.9x
- Shareholder yield (distributions): 0.9%
Not assessed (insufficient data or a ratio without meaning): ROIC, Net margin, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Listed companies from Denmark · same country · compared with 40 companies
Multiples and returns vs the median
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| DEMANT.CODemant A | 79.7 bn | 51.6 | 15.0% | 6.7% | +2.5% | +72% / +30% |
| PNDORA.COPandora A | 68.8 bn | 13.2 | 133.4% | 16.1% | unavailable | +16% / −3% |
| NEWCAP.CONewcap Holding A | 65.3 bn | 13,125.0 | 29.1% | 41.6% | −99.9% | +121% / +62% |
| ISS.COIss A | 50.8 bn | 19.8 | 27.7% | 3.1% | +1.1% | +43% / +158% |
| BAVA.COBavarian Nordic A | 19.2 bn | 13.9 | 10.9% | 22.0% | unavailable | +33% / +47% |
| GN.COGn Store Nord A | 18.1 bn | 27.7 | 6.3% | 6.8% | unavailable | +20% / −23% |
| NETC.CONetcompany Group A | 16.8 bn | 66.2 | 7.2% | 3.3% | unavailable | +11% / +64% |
| BIOMAR.COBiomar Group A | 12.1 bn | 16.9 | 28.3% | 4.3% | −0.5% | unavailable / unavailable |
| JDAN.COJeudan A | 11.1 bn | 11.1 | 7.7% | 57.1% | unavailable | +2% / −7% |
| DFDS.CODfds A | 8.7 bn | — | -0.2% | -0.1% | +1.9% | +73% / −25% |
| GUBRA.COGubra A | 4.8 bn | 2.9 | 149.6% | 64.1% | +892.2% | −40% / +157% |
| MATAS.COMatas A | 3.1 bn | 12.9 | 6.6% | 2.8% | +4.7% | −31% / −21% |
| CBRAIN.COCbrain A | 2.4 bn | 54.7 | 13.8% | 17.2% | −6.2% | −21% / −52% |
| BO.COBang & Olufsen A | 1.7 bn | — | -10.0% | -4.3% | −3.3% | −24% / +12% |
| COLUM.COColumbus A | 1.2 bn | 84.0 | 2.0% | 0.9% | unavailable | −5% / +30% |
| NNIT.CONnit A | 1.0 bn | — | -3.0% | -1.3% | −3.4% | −16% / −54% |
| NORTHM.CONorth Media A | 873.1 m | 13.2 | 5.5% | 5.1% | −0.4% | +11% / −16% |
| FFARMS.COFirstfarms A | 789.8 m | — | -2.3% | -5.4% | −16.5% | −9% / −1% |
| HUSCO.COHusCompagniet A | 507.2 m | — | -1.3% | -0.9% | +28.7% | −41% / −46% |
| BIOPOR.COBioporto A | 456.2 m | — | -117.6% | -203.8% | +11.2% | −8% / −53% |
| GABR.COGabriel Holding A | 429.4 m | 57.5 | 2.8% | 1.4% | +6.7% | −10% / −29% |
| GREENM.COGreenMobility A | 392.5 m | 11.9 | 74.3% | 21.5% | +20.0% | −19% / +91% |
| EGNETY.COEgnsinvest Ejendomme Tyskland A | 320.0 m | 13.0 | 4.0% | 40.9% | −2.6% | −21% / +11% |
| PFINV.COPapirfabrikken Invest A | 300.9 m | 13.5 | 5.4% | 29.7% | +0.9% | −3% / +36% |
| CEMAT.COCemat A | 213.9 m | 3.5 | 28.7% | 37.5% | +318.0% | −9% / +3% |
1- and 3-year price returns: for FED.CO from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Scenarios are not available. input data missing
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
No news in our archive over the last 180 days.
Annual reports (ESEF)
- Annual report 202628 Oct 2026
- Annual report 202602 Sept 2026
- Annual report 202629 Apr 2026
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.